Global Laxatives Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Type;

Hyperosmotic, Bulk-Forming, Stool Softeners, Lubricants, Stimulants, and Other.

By Administration;

Oral, and Rectal.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn674846840 Published Date: March, 2025 Updated Date: April, 2025

Introduction

Global Laxatives Market (USD Million), 2021 - 2031

In the year 2024, the Global Laxatives Market was valued at USD 7,208.57 million. The size of this market is expected to increase to USD 10,696.68 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.8%.

The global laxatives market has witnessed significant growth in recent years, driven by increasing awareness about digestive health and the rising prevalence of gastrointestinal disorders worldwide. Laxatives, medications designed to promote bowel movements, play a crucial role in managing conditions such as constipation, irritable bowel syndrome (IBS), and other gastrointestinal issues. This market encompasses a wide range of products, including bulk-forming agents, stimulants, osmotics, and lubricants, each catering to different patient needs and preferences.

Lifestyle changes, dietary habits, and aging populations have contributed to the growing demand for laxatives across various demographics. Moreover, advancements in pharmaceutical formulations and the introduction of novel ingredients have expanded the market's scope, offering safer and more effective treatment options. As healthcare systems worldwide focus more on preventive care and wellness, the demand for over-the-counter (OTC) laxatives has surged, reflecting a broader trend towards self-care and non-prescription remedies.

The competitive landscape of the global laxatives market is characterized by a mix of established pharmaceutical companies and innovative biotech firms striving to enhance product efficacy and patient compliance. Regulatory frameworks, consumer preferences, and economic factors also influence market dynamics significantly. Looking ahead, the market is poised for further growth as manufacturers continue to invest in research and development, aiming to address unmet medical needs and capitalize on evolving consumer expectations for digestive health solutions.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By Administration
    3. Market Snapshot, By Region
  4. Global Laxatives Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Aging Population
        2. Increasing Digestive Disorders
        3. Lifestyle Changes
        4. Rising Health Awareness
      2. Restraints
        1. Side Effects
        2. Regulatory Challenges
        3. Dependency Risks
      3. Opportunities
        1. Product Innovation
        2. Non-Prescription Demand
        3. E-commerce Expansion
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Laxatives Market, By Type, 2021 - 2031 (USD Million)
      1. Hyperosmotic
      2. Bulk-Forming
      3. Stool Softeners
      4. Lubricants
      5. Stimulants
      6. Other
    2. Global Laxatives Market, By Administration, 2021 - 2031 (USD Million)
      1. Oral
      2. Rectal
    3. Global Laxatives Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Bayer AG
      2. Boehringer Ingelheim Pharmaceuticals Inc.
      3. Eskag Pharma Pvt. Ltd.
      4. GlaxoSmithKline Plc
      5. Procter & Gamble Company
      6. Purdue Pharma L.P.
      7. Mallinckrodt Pharmaceuticals
      8. Abbott Laboratories
  7. Analyst Views
  8. Future Outlook of the Market